Clinical Trial Results: A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Follitropin Delta to placebo in men with idiopathic infertility showed results after termination; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Infertility
• Male Infertility

Drugs mentioned

• Follitropin Delta (follicle-stimulating hormone delta)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Male Idiopathic Infertility | Phase 2 | Status: TERMINATED | Results posted: 2026-08-28